Colcemid and econazole do not show aneugenicity in male mouse germ cells.
Colcemid (COM) and econazole (EZ) were tested for induction of mitotic arrest and C-mitotic effects in mouse bone marrow cells and for meiotic delay and induction of hyperploidy in mouse spermatocytes after single injection. Doses of 1 and 3 mg/kg COM were used and bone marrow and spermatocytes were sampled at 2, 6, 10, 14 and 18 h. For EZ a dose of 120 mg/kg and intervals of 6, 10, 14 and 18 h were chosen. At 2 h after COM treatment of bone marrow cells the mitotic index and C-mitotic effect were highest, then both decreased from 6 to 18 h. At 18 h the mitotic indices decreased to or significantly below the control level at doses of 1 and 3 mg/kg respectively, whereas the corresponding frequencies of C-mitotic cells were still significantly higher than in the controls. EZ also induced mitotic arrest and C-mitotic effects in mouse bone marrow cells. In contrast to COM, the effects of EZ were highest at 18 h after treatment. COM and EZ caused disturbances in progression from the first to second meiotic division, however, after COM treatment the ratios of MMII to MMI were significantly below the control. In contrast, after EZ treatment the ratios were significantly higher than in the controls. Such differences may result from the different mechanisms by which COM and EZ act on cell cycle progression. COM and EZ did not induce non-disjunction under the experimental conditions. However, EZ induced structural chromosomal aberrations.
Shi
Q
Q
GSF-Forschungszentrum für Umwelt und Gesundheit, Institut für Säugetiergenetik, Neuherberg, Germany.
Adler
I D
ID
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D003703:Demecolcine / Q000633:toxicity*; D004464:Econazole / Q000633:toxicity*; D008297:Male; D008540:Meiosis / Q000187:drug effects*; D051379:Mice; D008815:Mice, Inbred Strains; D008940:Mitotic Index / Q000187:drug effects*; D009152:Mutagenicity Tests; D013094:Spermatozoa / Q000187:drug effects*
D004464:Econazole; D003703:Demecolcine